Health discussions in Davos this week will center on AI, says Hackensack Meridian CEO Robert Garrett. Plus, updates on the 2024 presidential race and our Trends segment.
Marketers must ditch one-size-fits-all approach to pharma reputation: survey
The Real Chemistry survey points to the need for brand leaders to understand four distinct audiences within the healthcare realm — as well as the attitudes and perceptions of each.
Generative AI turns conference attendees into infectious disease warriors
Novartis in talks to buy Cytokinetics; Boston Scientific acquires medtech company Axonics in $3.7 billion deal; Lilly’s Zepbound obesity drug reaches 25,000 new prescriptions mark.
Compared to its performance in November, Vicks inched up in all three major categories as the nation drifted further into the heart of cold and flu season.